|
Do You Have an Alcohol or Drug Problem? (About.com)
Alcohol and drug use can progress into abuse and even addiction so insidiously that sometimes people do not realize that it has become a problem for them and those...
us.rd.yahoo.com
Watson Announces Positive Data For RAPAFLO(TM)(silodosin), Its Investigational Product For BPH, At Regional AUA ... (Medical News Today)
Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced that investigators presented efficacy and safety data on silodosin, its investigational treatment for benign prostatic hyperplasia (BPH, or prostate enlargement), at two regional meetings of the American Urological Association (AUA).
us.rd.yahoo.com
Transcept Pharmaceuticals Submits New Drug Application For Intermezzo(R) For Treatment Of Middle-of-the-Night Awakenings (Medical News Today)
Transcept Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its lead product candidate, Intermezzo(R) (zolpidem tartrate sublingual lozenge).
us.rd.yahoo.com
Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings (PR Newswire via Yahoo! Finance)
Transcept Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, announced today that it has submitted a New Drug Application to the U.S. Food and Drug Administration for its lead product candidate, Intermezzo® .
us.rd.yahoo.com
Health on the Web (New York Times)
A look at six of the most interesting and potentially useful online health resources.
us.rd.yahoo.com
Watson Announces Positive Data for RAPAFLO(TM)(silodosin), Its Investigational Product for BPH, at Regional AUA ... (PR Newswire via Yahoo! Finance)
Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced today that investigators presented efficacy and safety data on silodosin, its investigational treatment for benign prostatic hyperplasia , at two regional meetings of the American Urological Association .
us.rd.yahoo.com
Register User (Scarborough Mirror)
Men with testicular cancer need to be diagnosed and treated as soon as possible.
us.rd.yahoo.com
Pushing Back When Insurers Deny Coverage for Treatment (WallStreet Journal via Yahoo! Finance)
Strategies that can bolster your case in appealing a health insurer's denial of coverage.
us.rd.yahoo.com
Poland set to impose chemical castration after outrage over incest case (Times Online)
Poland, which has been enraged by a shocking case of incest, is likely to become the first EU country to give judges the right to impose chemical castration on convicted paedophiles.
us.rd.yahoo.com
Nymox's NX-1207 For The Treatment Of Benign Prostatic Hyperplasia In Phase 3 Program (Medical News Today)
Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to announce that results from the most recently completed clinical studies of NX-1207, the Company's investigational drug for the treatment of benign prostatic hyperplasia (BPH), will be presented on Thursday, September 25 at the 82nd Annual Meeting of the North Central Section of the American Urological Association being held in Chicago.
us.rd.yahoo.com
|
